Open Access
| Issue |
E3S Web Conf.
Volume 271, 2021
2021 2nd International Academic Conference on Energy Conservation, Environmental Protection and Energy Science (ICEPE 2021)
|
|
|---|---|---|
| Article Number | 03037 | |
| Number of page(s) | 5 | |
| Section | Research on Energy Chemistry and Chemical Simulation Performance | |
| DOI | https://doi.org/10.1051/e3sconf/202127103037 | |
| Published online | 15 June 2021 | |
- Binder, L.I. et al. The distribution of Tau in the mammalian central nervous system. The Journal of cell biology vol. 101,4 (1985): 1371–8. doi: 10.1083/jcb.101.4.1371 [CrossRef] [PubMed] [Google Scholar]
- Korgiopoulou, Christina. “Tau Post-Translational Modifications in Alzheimer's Disease: Diagnostic and Therapeutic Opportunities: StressMarq.” 1 June 2020, www.stressmarq.com/tau-post-translational-modific ations-alzheimers-disease-diagnostic-therapeutic-op portunities/?v=3e8d115eb4b [Google Scholar]
- Friedhoff, P. et al. “Structure of tau protein and assembly into paired helical filaments.” Biochimica et biophysica acta vol. 1502,1 (2000): 122–32. doi: 10.1016/s0925-4439(00)00038-7 [CrossRef] [PubMed] [Google Scholar]
- Mandelkow, Eva-Maria, et al. “MARK/PAR1 Kinase is a Regulator of Microtubule-Dependent Transport in Axons.” Journal of Cell Biology vol. 167, no. 1, 2004, pp. 99–110., doi: 10.1083/jcb.200401085. [CrossRef] [Google Scholar]
- Xu, Shaohua, et al. “Characterization of Tau Fibrillization in Vitro.” Alzheimer's & Dementia, vol. 6, no. 2, 2010, pp. 110–117., doi: 10.1016/j.jalz.2009.06.002. [CrossRef] [Google Scholar]
- Künze, Georg, et al. “Binding of the Three-Repeat Domain of Tau to Phospholipid Membranes Induces an Aggregated-like State of the Protein.” Biochimica Et Biophysica Acta (BBA) - Biomembranes, vol. 1818, no. 9, 2012, pp. 2302–2313., doi: 10.1016/j.bbamem.2012.03.019. [CrossRef] [Google Scholar]
- Goedert, Michel, and Ross Jakes. “Mutations Causing Neurodegenerative Tauopathies.” Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1739, no. 2-3, 2005, pp. 240–250., doi: 10.1016/j.bbadis.2004.08.007. [CrossRef] [Google Scholar]
- Friedhoff, P. et al. “A nucleated assembly mechanism of Alzheimer paired helical filaments.” Proceedings of the National Academy of Sciences of the United States of America vol. 95,26 (1998): 15712–7. doi: 10.1073/pnas.95.26.15712 [CrossRef] [Google Scholar]
- Friedhoff, P. et al. “Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution.” Biochemistry vol. 37,28 (1998): 10223–30. doi: 10.1021/bi980537d [CrossRef] [Google Scholar]
- Liu, Shi Jie, et al. “Tau Becomes a More Favorable Substrate for GSK-3 When It Is Prephosphorylated by PKA in Rat Brain.” Journal of Biological Chemistry, vol. 279, no. 48, 2004, pp. 50078–50088., doi: 10.1074/jbc.m406109200. [CrossRef] [Google Scholar]
- Lim, Jormay, and Kun Ping Lu. “Pinning down Phosphorylated Tau and Tauopathies.” Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1739, no. 2-3, 2005, pp. 311–322., doi: 10.1016/j.bbadis.2004.10.003. [CrossRef] [Google Scholar]
- Ittner, Arne et al. “Site-specific phosphorylation of tau inhibits amyloid-ß toxicity in Alzheimer's mice.” Science (New York, N.Y.) vol. 354,6314 (2016): 904–908. doi: 10.1126/science.aah6205 [CrossRef] [Google Scholar]
- Durany, N., et al. “Investigations on Oxidative Stress and Therapeutical Implications in Dementia.” European Archives of Psychiatry and Clinical Neurosciences, vol. 249, no. S3, 1999, doi: 10.1007/pl00014177. [Google Scholar]
- Sayre, Lawrence M., et al. “In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease.” Journal of Neurochemistry, vol. 74, no. 1, 2001, pp. 270–279., doi: 10.1046/j.1471-4159.2000.0740270.x. [CrossRef] [Google Scholar]
- Keck, Susi, et al. “Proteasome Inhibition by Paired Helical Filament-Tau in Brains of Patients with Alzheimer's Disease.” Journal of Neurochemistry, vol. 85, no. 1, 2003, pp. 115–122., doi: 10.1046/j.1471-4159.2003.01642.x. [CrossRef] [PubMed] [Google Scholar]
- Hanger, Diane P. et al. “Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.” Trends in molecular medicine vol. 15,3 (2009): 112–9. doi: 10.1016/j.molmed.2009.01.003 [CrossRef] [PubMed] [Google Scholar]
- Castellani, Rudy J. et al. “Phosphorylated tau: toxic, protective, or none of the above.” Journal of Alzheimer's disease: JAD vol. 14,4 (2008): 377–83. doi: 10.3233/jad-2008-14404. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.